-
Biostatistics/Epidemiology
2015
Proposal 15-11
Use of an incentive to increase biologic sample (Oragene) participation.
Author(s): Aaron McDonald
-
Cancer Control, Chronic Disease
2015
Proposal 15-10
Financial Burden in Survivors of Childhood Cancer: the Childhood Cancer Survivor Study.
Citation: J Clin Oncol 2017 Oct 20;35(30):3474-3481
Author(s): Ryan Nipp
-
Cancer Control, Chronic Disease
2015
Proposal 15-09
How Costs of Health Care Affect Utilization and Financial Burden in the Childhood Cancer Survivor Study.
Citation: J Clin Oncol 2017 Oct 20;35(30):3474-3481
Author(s): Douglas Fair
-
Proposal 15-08
Impact of Radiation Dose and Volume to the Pancreas on Subsequent Risk of Diabetes Mellitus in Long-term Survivors of Childhood Cancer Treated with Abdominal Radiation: A Report from the Childhood Cancer Survivor Study.
Citation: J Natl Cancer Inst 2020 May 1;112(5):525-532
Author(s): Danielle Novetsky Friedman
-
Chronic Disease, Second Malignancy, Cancer Control, Psychology, Biostatistics/Epidemiology
2015
Proposal 15-07
Changes in Long-Term Outcomes in Hodgkin Lymphoma Survivors with Contemporary Risk-Adapted Therapy.
Author(s): Kevin Oeffinger
-
Genetics, Second Malignancy, Biostatistics/Epidemiology
2015
Proposal 15-06
Exome sequencing to discover genetic variants that predispose childhood cancer survivors to the development of subsequent neoplasms.
Author(s): Lindsay M. Morton
-
Proposal 15-05
Cyclophosphamide Equivalent Dosing and Male Health Late Effects – Infertility, Erectile Dysfunction, Sexual Function and Testosterone Replacement Therapy in Survivors diagnosed from 1970-1986: A report from the Childhood Cancer Survivor Study.
Citation: Cancer 2018 Jun 1;124(11):2447-2455
Author(s): Lillian Meacham
-
Proposal 15-04
The risk of breast and thyroid cancer after radiotherapy for Hodgkin’s Lymphoma: Can reconstructed dosimetry data be used to predict secondary malignancies?
Author(s): David Hodgson
-
Chronic Disease, Second Malignancy
2015
Proposal 15-03
Comparison of risks of mortality (all-cause, cause-specific) and invasive second or subsequent cancers: a Childhood Cancer Survivor Study and British Childhood Cancer Survivor Study collaboration.
Citation: J Natl Cancer Inst 2021 May 4;113(50:562-571
Author(s): Miranda Fidler
-
Proposal 15-02
Esophageal disease after childhood cancer therapy: Experience from three childhood cancer survivor cohorts.
Citation: Pediatr Blood Cancer 2021 Aug;68(8):e29043
Author(s): Peter H. Asdahl